A Unique Investment
Opportunity
De-risked Program for Osteoarthritis
More than 350 patients have already experienced the power of MOTYS™ to reduce pain, improve mobility and delay the progression of the disease
Unparalleled Efficacy
We are confident that MOTYS™ will change the trajectory of osteoarthritis and return millions of patients to pain free, active lives
A Singular Focus
Doron Therapeutics was founded to ensure that MOTYS™ becomes a clinical reality and a commercial success
Osteoarthritis is a growing epidemic with no disease modifying therapies
Second most costly health condition treated at US hospitals
%
Lifetime risk of symptomatic osteoarthritis
Fastest growing cause of disability worldwide
OA is the leading cause of chronic opioid use in the US
Prevalence driven by aging population, obesity, and participation in high impact sports
Contact Us
Our team can help to answer any of your questions.
Get in touch to learn more about Doron Therapeutics.